In a multi-billion dollar industry, there are countless diet plans, products, and meal suggestions in…
Browsing: drug risks
The leukemia drug Mylotarg (gemtuzumab ozogamicin), which was voluntarily withdrawn from the market in 2010 over safety concerns and questions…
Would allowing pharmaceutical companies to include fewer risks in television and print ads be good for consumers? Members of the…
Between 1999 and 2014, antidepressant use by Americans increased by 65%. By 2014, 1 in 8 Americans (12.7%) 12 and…
The late 1990s and early 2000s saw a number of prescription drugs come to market that ended up causing grave…
Are consumers inundated with risks and side effects in drug ads to the point they don’t pay attention to that…
About MedShadow
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
FIND ARTICLES
Conditions
Symptoms & Concerns
Medications
SUPPORT
Contribute
Donate
Contact
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward
